BiferaRx is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alaven Pharmaceutical Llc. The primary component is Folic Acid; Heme Iron Polypeptide; Iron Dextran; Cyanocobalamin.
| Product ID | 68220-085_ff690efc-acac-4103-98ad-3a1613dc5573 |
| NDC | 68220-085 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BiferaRx |
| Generic Name | Folic Acid, Heme Iron Polypeptide, Iron Dextran, And Cyanocobalamin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-05-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Alaven Pharmaceutical LLC |
| Substance Name | FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; CYANOCOBALAMIN |
| Active Ingredient Strength | 1 mg/1; mg/1; mg/1; ug/1 |
| Pharm Classes | Vitamin B 12 [CS],Vitamin B12 [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2010-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | Unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-05-01 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | Unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-05-01 |
| Marketing End Date | 2019-09-30 |
| Marketing Category | Unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-05-01 |
| Marketing End Date | 2019-09-30 |
| Ingredient | Strength |
|---|---|
| FOLIC ACID | 1 mg/1 |
| SPL SET ID: | a7c1400a-d230-45db-afff-d5f70b091ee9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BIFERARX 77740362 3851059 Live/Registered |
Alaven Pharmaceutical LLC 2009-05-19 |